enVVeno Medical (NVNO) Receivables (2017 - 2022)

enVVeno Medical (NVNO) posted quarterly Receivables of $38000.0 for Q2 2022, up 43.32% quarter-over-quarter from $26515.0 in Q1 2019.

enVVeno Medical (NVNO) Receivables (2017 - 2022) Analysis & Trends

enVVeno Medical's Receivables history runs 4 years deep, the most recent figure standing at $38000.0 for Q2 2022.

In Q2 2022, Receivables changed N/A year-over-year to $38000.0; the TTM figure through Jun 2022 stood at $38000.0 (changed N/A YoY), while the FY2018 annual figure was $32022.0, down 8.98% from the prior year.
Receivables for Q2 2022 stood at $38000.0, up from $26515.0 in the prior quarter.
The five-year high for Receivables was $38000.0 in Q2 2022, with the low at $26515.0 in Q1 2019.
The 3-year median for Receivables is $28964.0 (2018), against an average of $30712.6.
Peak annual rise in Receivables reached 8.98% in 2018, while the deepest fall reached 8.98% in 2018.
enVVeno Medical's Receivables stood at $32022.0 in 2018, then dropped by 17.2% to $26515.0 in 2019, then jumped by 43.32% to $38000.0 in 2022.
Business Quant data shows NVNO's Receivables at $38000.0 in Q2 2022, $26515.0 in Q1 2019, and $32022.0 in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Receivables (Qtr)
1	Abbott Laboratories	199.12 Bn	193.52 Bn	7.27 Bn	8.60 Bn
2	Stryker	128.79 Bn	125.32 Bn	4.50 Bn	3.74 Bn
3	Medtronic	119.30 Bn	110.08 Bn	6.41 Bn	6.64 Bn
4	Boston Scientific	73.50 Bn	72.96 Bn	3.85 Bn	3.18 Bn
5	Edwards Lifesciences	52.11 Bn	47.86 Bn	1.35 Bn	955.70 Mn
6	Dexcom	34.62 Bn	32.67 Bn	830.00 Mn	1.28 Bn
7	GE HealthCare Technologies	34.05 Bn	31.94 Bn	2.18 Bn	4.66 Bn
8	Koninklijke Philips	26.42 Bn	23.10 Bn	4.55 Bn	4.12 Bn
9	Steris	23.15 Bn	22.67 Bn	684.20 Mn	1.01 Bn
10	enVVeno Medical	6.92 Mn	6.92 Mn	-	-

Download Data